| 000 | 04747nam a2200841 i 4500 | ||
|---|---|---|---|
| 001 | 20143378153 | ||
| 003 | CtWfDGI | ||
| 005 | 20201203115808.0 | ||
| 006 | m o d | ||
| 007 | cr zn||||uuuuu | ||
| 008 | 150309t20142014enkad ob 001 0 eng d | ||
| 020 |
_z9781780642000 _qalk. paper |
||
| 040 |
_aCtWfDGI _beng _erda _cCtWfDGI |
||
| 050 | 1 | 4 |
_aQP171 _b.M483 2014eb |
| 082 | 0 | 4 |
_a572.4 _223 |
| 245 | 0 | 0 |
_aMetabolomics and systems biology in human health and medicine / _cedited by Oliver A.H. Jones, School of Applied Sciences, RMIT University, Melbourne, Australia. |
| 264 | 1 |
_aWallingford, Oxfordshire, UK : _bCABI, _c2014. |
|
| 264 | 4 | _c2014 | |
| 300 |
_a1 online resource (xiii, 192 pages) : _billustrations, charts |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 530 | _aAlso available in print format. | ||
| 520 | 3 | _aThis book provides a solid introduction to medical metabolomics and systems biology, and demonstrates how they have been applied to studies in medicine and human health, including nutrition and pathogenic microorganisms. Following core themes of diagnosis, pathology and aetiology of diseases, this book provides a reference for health care professionals interested in how to use metabolomics for medical research, especially research on neuroscience/neurology, cardiovascular disease and health, chronic obstructive pulmonary disease, liver diseases, digestive health, infectious diseases, type 2 diabetes mellitus and metabolic syndrome, skeletal muscle metabolism and dysfunction, and neoplasms. | |
| 505 | 0 | _aAn introduction to metabolomics and systems biology / Mahon L. Maguire -- Metabolomics in neuroscience and neurology / Reza M. Salek -- Cardiovascular disease and health / Jacqueline E. Wood -- Chronic obstructive pulmonary disease (COPD) and metabolomics / Baljit K. Ubhi, John H. Riley, Julian L. Griffin and Susan C. Connor -- In search of new biomarkers for liver diseases / Luigi Atzori and Maria L. Santoru -- Influences shaping digestive health explored using metabolomics / Anisha Wijeyesekera, Frances Jackson and Jonathan Swann -- Applications of metabolomics in the study of pathogenic microorganisms and their effects on human health / Daniel A. Dias and Ute Roessner -- Type 2 diabetes mellitus and the metabolic syndrome / Lee D. Roberts -- Biomarkers of skeletal muscle regulation, metabolism, and dysfunction / Jane Shearer and Aalim M. Weljie -- Applications of metabolomics in cancer research / Julian L. Griffin. | |
| 504 | _aIncludes bibliographical references and index. | ||
| 506 | _aAccess limited to subscribing institution. | ||
| 588 | _aTitle from PDF title page (viewed March 9, 2015). | ||
| 650 | 0 | _aSystems biology. | |
| 650 | 0 | _aCardiovascular system. | |
| 650 | 1 | 2 | _aMetabolomics. |
| 650 | 2 | 2 | _aBiomedical Research. |
| 650 | 2 | 2 | _aSystems Biology. |
| 650 | 4 | _aPhysiology of Human Nutrition. | |
| 650 | 4 | _aNutrition related Disorders and Therapeutic Nutrition. | |
| 650 | 4 | _aPrion, Viral, Bacterial and Fungal Pathogens of Humans, (New March 2000) | |
| 650 | 4 | _aNon-communicable Human Diseases and Injuries. | |
| 650 | 4 | _aDiagnosis of Human Disease, (New March 2000) | |
| 650 | 4 | _aMolecular Biology and Molecular Genetics, (Discontinued March 2000, Reinstated and Revised June 2002) | |
| 650 | 7 |
_aCardiovascular diseases. _2cabt |
|
| 650 | 7 |
_aCardiovascular system. _2cabt |
|
| 650 | 7 |
_aChronic obstructive pulmonary disease. _2cabt |
|
| 650 | 7 |
_aDiagnosis. _2cabt |
|
| 650 | 7 |
_aDigestive system. _2cabt |
|
| 650 | 7 |
_aHuman diseases. _2cabt |
|
| 650 | 7 |
_aInfections. _2cabt |
|
| 650 | 7 |
_aInfectious diseases. _2cabt |
|
| 650 | 7 |
_aLiver. _2cabt |
|
| 650 | 7 |
_aLiver diseases. _2cabt |
|
| 650 | 7 |
_aLungs. _2cabt |
|
| 650 | 7 |
_aMedical research. _2cabt |
|
| 650 | 7 |
_aMetabolic syndrome. _2cabt |
|
| 650 | 7 |
_aMetabolism. _2cabt |
|
| 650 | 7 |
_aMetabolites. _2cabt |
|
| 650 | 7 |
_aMetabolomics. _2cabt |
|
| 650 | 7 |
_aNeoplasms. _2cabt |
|
| 650 | 7 |
_aNervous system. _2cabt |
|
| 650 | 7 |
_aNeurology. _2cabt |
|
| 650 | 7 |
_aNutrition. _2cabt |
|
| 650 | 7 |
_aPathogens. _2cabt |
|
| 650 | 7 |
_aSkeletal muscle. _2cabt |
|
| 650 | 7 |
_aType 2 diabetes. _2cabt |
|
| 690 | _aVV120 | ||
| 690 | _aVV130 | ||
| 690 | _aVV210 | ||
| 690 | _aVV600 | ||
| 690 | _aVV720 | ||
| 690 | _aZZ360 | ||
| 700 | 1 |
_aJones, Oliver A. H., _ecompiler. |
|
| 710 | 2 |
_aC.A.B. International, _eissuing body. |
|
| 776 | 0 | 8 |
_iPrint version: _tMetabolomics and systems biology in human health and medicine. _dWallingford, Oxfordshire : CAB International, [2014] _z9781780642000 (alk. paper) _w(DLC)2014002485 |
| 856 | 4 | 0 |
_uhttps://dx.doi.org/10.1079/9781780642000.0000 _zClick here to access resource |
| 942 | _cEB | ||
| 999 |
_c312704 _d312704 |
||